Delisting riskPopularity #5,422
ProPhase Labs (PRPH)
Operator of whole-genome sequencing, esophageal diagnostics, and OTC supplement brands.
$0.0100
vs last close+0.00 (+11.11%)
Something off on this page? Send us feedback.
Next report
Nov 16, 26
estimated · in 55 days
EPS estimate
$2.05
Revenue estimate
$12.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26Jun '26Aug '26Nov '26
Reported−$1.86−$1.20−$1.10−$1.60−$0.87−$0.43−$0.22Pending
Estimate−$0.24−$1.80−$1.50−$1.10−$1.20−$1.20—$2.05
Surprise−675.0%+33.3%+26.7%−45.5%+27.5%+64.2%——
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26Jun '26Aug '26Nov '26
Reported$19.0M$1.4M$1.2M$883.0K$784.0K$478.0K$1.0MPending
Estimate$3.8M$2.5M$3.6M$5.7M$9.7M$9.7M—$12.0M
Surprise+402.7%−41.6%−64.9%−84.5%−91.9%−95.1%——
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2031 | −$1.20 | — | — |
| Dec 2030 | −$1.10 | — | — |
| Sep 2030 | −$1.50 | — | — |
| Jun 2030 | −$1.80 | — | — |
| Mar 2030 | −$3.10 | — | — |
| Dec 2029 | −$0.80 | — | — |
| Sep 2029 | −$2.80 | — | — |
| Jun 2029 | −$2.60 | — | — |
| Mar 2029 | −$1.95 | — | — |
| Dec 2028 | −$1.40 | — | — |
| Sep 2028 | −$1.00 | — | — |
| Jun 2028 | $0.25 | — | — |
| Mar 2028 | $1.90 | — | — |
| Dec 2027 | $1.77 | — | — |
| Sep 2027 | $3.85 | — | — |
| Jun 2027 | $4.40 | — | — |
| Mar 2027 | −$0.85 | — | — |
| Dec 2026 | $1.90 | — | — |
| Nov 2026 | $2.05 | — | — |
| Aug 2026 | — | −$0.22 | — |
| Jun 2026 | −$1.20 | −$0.43 | +64.2% |
| Apr 2026 | −$1.20 | −$0.87 | +27.5% |
| Nov 2025 | −$1.10 | −$1.60 | −45.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 2031 | −$1.20 | — | — | $9.7M | — | — | — |
| Dec 2030 | −$1.10 | — | — | $5.7M | — | — | — |
| Sep 2030 | −$1.50 | — | — | $3.6M | — | — | — |
| Jun 2030 | −$1.80 | — | — | $2.5M | — | — | — |
| Mar 2030 | −$3.10 | — | — | $2.8M | — | — | — |
| Dec 2029 | −$0.80 | — | — | $18.4M | — | — | — |
| Sep 2029 | −$2.80 | — | — | $9.9M | — | — | — |
| Jun 2029 | −$2.60 | — | — | $10.7M | — | — | — |
| Mar 2029 | −$1.95 | — | — | $13.1M | — | — | — |
| Dec 2028 | −$1.40 | — | — | $14.1M | — | — | — |
| Sep 2028 | −$1.00 | — | — | $15.1M | — | — | — |
| Jun 2028 | $0.25 | — | — | $20.5M | — | — | — |
| Mar 2028 | $1.90 | — | — | $21.4M | — | — | — |
| Dec 2027 | $1.77 | — | — | $20.0M | — | — | — |
| Sep 2027 | $3.85 | — | — | $24.3M | — | — | — |
| Jun 2027 | $4.40 | — | — | $28.6M | — | — | — |
| Mar 2027 | −$0.85 | — | — | $9.0M | — | — | — |
| Dec 2026 | $1.90 | — | — | $14.6M | — | — | — |
| Nov 16, 2026 | $2.05 | — | — | $12.0M | — | — | — |
| Aug 19, 2026 | — | −$0.22 | — | — | $1.0M | — | −6.8% |
| Jun 30, 2026 | −$1.20 | −$0.43 | +64.2% | $9.7M | $478.0K | −95.1% | −2.2% |
| Apr 14, 2026 | −$1.20 | −$0.87 | +27.5% | $9.7M | $784.0K | −91.9% | +7.7% |
| Nov 19, 2025 | −$1.10 | −$1.60 | −45.5% | $5.7M | $883.0K | −84.5% | −9.3% |
| Aug 13, 2025 | |||||||
| May 20, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 15, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 28, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 26, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 12, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 26, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 20, 2018 | |||||||
| May 14, 2018 | |||||||
| Mar 21, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Aug 11, 2017 | |||||||
| May 15, 2017 | |||||||
| Feb 27, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 29, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 12, 2015 |